Nosa Med AB (NOSA) — Cash Flow-to-Debt Ratio
Nosa Med AB (NOSA) has a Cash Flow-to-Debt Ratio of -0.08x as of December 2025, meaning its operating cash flow of Skr-1.78 Million could theoretically repay 0% of its total liabilities (Skr23.65 Million) in one year. Check NOSA cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Nosa Med AB Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Nosa Med AB across 10 annual periods. Also explore Nosa Med AB asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Nosa Med AB (2016–2025)
Year-by-year debt coverage analysis for Nosa Med AB. For market capitalisation and broader financial context, see Nosa Med AB market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.27x | Skr-6.39 Million | Skr23.65 Million | ▲ +88.8% |
| 2024 | -2.42x | Skr-10.03 Million | Skr4.14 Million | ▲ +12.4% |
| 2023 | -2.76x | Skr-17.50 Million | Skr6.33 Million | ▼ -33.0% |
| 2022 | -2.08x | Skr-6.93 Million | Skr3.33 Million | ▲ +67.2% |
| 2021 | -6.33x | Skr-6.21 Million | Skr980.00K | ▼ -32.3% |
| 2020 | -4.79x | Skr-69.96 Million | Skr14.61 Million | ▼ -43.4% |
| 2019 | -3.34x | Skr-52.72 Million | Skr15.79 Million | ▼ -35.2% |
| 2018 | -2.47x | Skr-35.09 Million | Skr14.21 Million | ▲ +33.4% |
| 2017 | -3.71x | Skr-27.78 Million | Skr7.49 Million | ▲ +43.2% |
| 2016 | -6.53x | Skr-23.48 Million | Skr3.60 Million | — |